Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IONS
IONS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IONS News
Ionis Pharmaceuticals to Host Q1 2026 Financial Results Webcast on April 29
6d ago
Newsfilter
A Doctor's Journey with His Son's Rare Disease
Apr 09 2026
CNBC
FDA Approves High Dose SPINRAZA for SMA Treatment
Mar 30 2026
Newsfilter
GSK Seeks EMA Approval for Bepirovirsen in Chronic Hepatitis B Treatment
Mar 27 2026
NASDAQ.COM
Ionis Pharmaceuticals Lowers Tryngolza Price to Enhance Competitive Positioning
Mar 26 2026
Newsfilter
When Insider Selling Can Be Positive: 2 Stocks to Keep an Eye On
Mar 23 2026
Marketbeat
Ionis Pharmaceuticals Receives FDA Priority Review for Zilganersen
Mar 23 2026
seekingalpha
Ionis Pharmaceuticals Receives FDA Priority Review for Zilganersen
Mar 23 2026
Newsfilter
U.S.-Iran Conflict Triggers Volatility in Healthcare Stocks
Mar 16 2026
seekingalpha
UniQure's Gene Therapy Faces FDA Challenges
Mar 05 2026
CNBC
Biogen Unveils New Research Data on Spinal Muscular Atrophy
Mar 05 2026
Newsfilter
Ionis Pharmaceuticals Unveils New Data for DAWNZERA at AAAAI 2026
Feb 27 2026
Newsfilter
Ionis Pharmaceuticals Receives FDA Priority Review for Olezarsen
Feb 26 2026
Newsfilter
Ionis Pharmaceuticals Q4 2025 Earnings Call Highlights
Feb 25 2026
seekingalpha
Ionis Pharmaceuticals Reports Better-Than-Expected Q4 Results
Feb 25 2026
Benzinga
Ionis Pharmaceuticals Q4 2023 Earnings Report Analysis
Feb 25 2026
seekingalpha
Show More News
